XML 82 R68.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' equity - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Options Outstanding          
Outstanding, beginning balance (in shares) 20,342,259        
Outstanding, ending balance (in shares) 19,703,879   20,342,259    
2021 Stock incentive Plan          
Options Outstanding          
Outstanding, beginning balance (in shares) 19,942,259        
Granted (in shares) 0        
Exercised (in shares) (376,578)        
Canceled (in shares) (261,802)        
Outstanding, ending balance (in shares) 19,303,879   19,942,259    
Weighted Average Exercise Price          
Outstanding, beginning balance (in USD per share) $ 9.70        
Granted (in USD per share) 0        
Exercised (in USD per share) 4.03        
Canceled (in USD per share) 15.06        
Outstanding, ending balance (in USD per share) $ 9.74   $ 9.70    
Outstanding, Weighted Average Remaining Contractual Term (in years) 7 years 10 months 17 days   8 years 1 month 20 days    
Outstanding, Aggregate Intrinsic Value $ 102,880   $ 226,350    
Vested and Expected to Vest, Awards Outstanding (in shares) 19,303,879        
Vested and Expected to Vest, Weighted Average Exercise Price (in USD per shares) $ 9.74        
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (in years) 7 years 10 months 17 days        
Vested and Expected to Vest, Aggregate Intrinsic Value $ 102,880        
Exercisable, Awards Outstanding (in shares) 9,129,677        
Exercisable, Weighted Average Exercise Price (in USD per share) $ 5.30        
Exercisable, Weighted Average Remaining Contractual Term (in years) 7 years 3 months        
Exercisable, Aggregate Intrinsic Value $ 67,191        
Performance-Based Awards          
Options Outstanding          
Granted (in shares)       350,000 50,000
Performance-Based Awards | Amended and Restated 2010 Equity Incentive Plan          
Options Outstanding          
Outstanding, beginning balance (in shares) 400,000        
Granted (in shares) 0        
Exercised (in shares) 0        
Canceled (in shares) 0        
Outstanding, ending balance (in shares) 400,000   400,000    
Weighted Average Exercise Price          
Outstanding, beginning balance (in USD per share) $ 10.12        
Granted (in USD per share)        
Exercised (in USD per share)        
Canceled (in USD per share)        
Outstanding, ending balance (in USD per share) $ 10.12   $ 10.12    
Outstanding, Weighted Average Remaining Contractual Term (in years) 8 years 4 months 9 days 8 years 7 months 6 days      
Outstanding, Aggregate Intrinsic Value $ 936   $ 3,768    
Vested and Expected to Vest, Awards Outstanding (in shares) 400,000        
Vested and Expected to Vest, Weighted Average Exercise Price (in USD per shares) $ 10.12        
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (in years) 8 years 4 months 9 days        
Vested and Expected to Vest, Aggregate Intrinsic Value $ 936        
Exercisable, Awards Outstanding (in shares) 179,166        
Exercisable, Weighted Average Exercise Price (in USD per share) $ 10.94        
Exercisable, Weighted Average Remaining Contractual Term (in years) 8 years 7 months 2 days        
Exercisable, Aggregate Intrinsic Value $ 272